Literature DB >> 29121542

Risk factors for three-month mortality after discharge in a cohort of non-oncologic hospitalized elderly patients: Results from the REPOSI study.

Luca Pasina1, Laura Cortesi2, Mara Tiraboschi3, Alessandro Nobili2, Giovanna Lanzo2, Mauro Tettamanti2, Carlotta Franchi2, Pier Mannuccio Mannucci4, Silvia Ghidoni3, Andrea Assolari3, Antonio Brucato3.   

Abstract

BACKGROUND: Short-term prognosis, e.g. mortality at three months, has many important implications in planning the overall management of patients, particularly non-oncologic patients in order to avoid futile practices. The aims of this study were: i) to investigate the risk of three-month mortality after discharge from internal medicine and geriatric wards of non-oncologic patients with at least one of the following conditions: permanent bedridden status during the hospital stay; severely reduced kidney function; hypoalbuminemia; hospital admissions in the previous six months; severe dementia; ii) to establish the absolute risk difference of three-month mortality of bedridden compared to non-bedridden patients.
METHODS: This prospective cohort study was run in 102 Italian internal medicine and geriatric hospital wards. The sample included all patients with three-months follow-up data. Bedridden condition was defined as the inability to walk or stand upright during the whole hospital stay. The following parameters were also recorded: estimated GFR≤29mL/min/1.73m2; severe dementia; albuminemia ≪2.5g/dL; hospital admissions in the six months before the index admission.
RESULTS: Of 3915 patients eligible for the analysis, three-month follow-up were available for 2058, who were included in the study. Bedridden patients were 112 and the absolute risk difference of mortality at three months was 0.13 (CI 95% 0.08-0.19, p≪0.0001). Logistic regression analysis also adjusted for age, sex, number of drugs and comorbidity index found that bedridden condition (OR 2.10, CI 95% 1.12-3.94), severely reduced kidney function (OR 2.27, CI 95% 1.22-4.21), hospital admission in the previous six months (OR 1.96, CI 95% 1.22-3.14), severe dementia (with total or severe physical dependence) (OR 4.16, CI 95% 2.39-7.25) and hypoalbuminemia (OR 2.47, CI 95% 1.12-5.44) were significantly associated with higher risk of three-month mortality.
CONCLUSIONS: Bedridden status, severely reduced kidney function, recent hospital admissions, severe dementia and hypoalbuminemia were associated with higher risk of three-month mortality in non-oncologic patients after discharge from internal medicine and geriatric hospital wards.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bedridden; Frailty; Mortality; Prognosis

Mesh:

Year:  2018        PMID: 29121542     DOI: 10.1016/j.archger.2017.10.016

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  4 in total

Review 1.  Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register.

Authors:  Pier Mannuccio Mannucci; Alessandro Nobili; Luca Pasina
Journal:  Intern Emerg Med       Date:  2018-08-31       Impact factor: 3.397

2.  Clinico-pathological Features of Colon Cancer Patients Undergoing Emergency Surgery: A Comparison Between Elderly and Non-elderly Patients.

Authors:  Gianluca Costa; Barbara Frezza; Pietro Fransvea; Giulia Massa; Mario Ferri; Paolo Mercantini; Genoveffa Balducci; Antonio Buondonno; Aldo Rocca; Graziano Ceccarelli
Journal:  Open Med (Wars)       Date:  2019-10-02

3.  Factors associated with death in bedridden patients in China: A longitudinal study.

Authors:  Jing Cao; Tiantian Wang; Zhen Li; Ge Liu; Ying Liu; Chen Zhu; Jing Jiao; Jiaqian Li; Fangfang Li; Hongpeng Liu; Huaping Liu; Baoyun Song; Jingfen Jin; Yilan Liu; Xianxiu Wen; Shouzhen Cheng; Xia Wan; Xinjuan Wu
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

4.  Alzheimer's disease medication and outcomes of hospitalisation among patients with dementia.

Authors:  T Möllers; L Perna; H Stocker; P Ihle; I Schubert; B Schöttker; L Frölich; J Bauer; H Brenner
Journal:  Epidemiol Psychiatr Sci       Date:  2019-11-14       Impact factor: 6.892

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.